§ 01
What Is High-Intensity Laser Therapy?
High-intensity laser therapy (HILT) applies laser energy through the skin as a clinician-delivered pain treatment. Published protocols include 1064 nm systems and high-power devices using 810/980 nm. HILT should be distinguished from low-level laser therapy and from laser acupuncture.
For muscle pain, the most directly relevant studies involve the trapezius. Some trials report an added benefit for pain and neck-related disability when laser accompanies rehabilitation. Studies of myogenic TMD, subacromial pain and chronic low-back pain support discussion of those specific regional applications.
A useful laser treatment helps a person move or perform a limited activity more comfortably. That improvement should be measured alongside the exercise program.
Choose treatment around a defined clinical problem and an activity goal, such as turning the head or reaching. A trained clinician documents the device protocol, protects the eyes and monitors the skin while following the rehabilitation response.
§ 02
Laser Delivery and Protocols
Continuous Emission
Wavelength:Device-specific
Power:Report average power, in watts
Targeting:Clinical region defined by assessment
Pros
- Energy is emitted continuously while the beam is activated.
- Power, exposure time and treated area together describe the applied dose.
- Treatment selection starts with the clinical condition and the region examined.
- The operator follows the device protocol for handpiece movement and skin monitoring.
- The operator records the treated area and exposure time alongside power.
Best For →Application: Protocols specifying continuous emission for the assessed condition
Pulsed Emission
Wavelength:Examples include 810/980 nm and 1064 nm
Power:Peak and average power are different measurements
Targeting:Upper-trapezius scanning in the 2025 trial
Pros
- Energy is delivered in pulses, with off-periods between them.
- Record peak power, average power and pulse timing separately.
- The 2025 upper-trapezius study reported a 15 W device, 30 kHz and a 20–50% duty cycle.
- That protocol used 810/980 nm wavelengths and scanning over the upper trapezius.
- The clinician matches the delivery settings to the selected device and indication.
Best For →Application: Protocols specifying pulse frequency, duration and duty cycle
§ 03
What the Treatment Does
The treatment delivers light with defined physical settings. Clinical assessment then tracks pain, disability and movement; the contribution of individual biological mechanisms remains uncertain.
Light Delivery
HILT applies near-infrared laser energy to a defined body region. Wavelength, tissue absorption and scattering affect light delivery. Clinical protocols describe where and how the handpiece is applied.
Thermal Effects
Absorbed laser energy can heat skin and tissue. Exposure depends on power, pulse timing, treated area and handpiece movement. The operator monitors the skin and pauses for burning or sharply localized heat.
Photobiomodulation
Photobiomodulation describes light-related changes in cellular activity. Its contribution to clinical HILT outcomes remains uncertain; pain relief and functional improvement are the outcomes used to judge treatment.
Pain and Function
Trials measure pain ratings, activity limitation and movement. For an individual course, repeat the same painful movement or daily task to assess whether the added procedure is useful.
What to Assess During a HILT Course
Defined Target
Name the assessed condition and painful region before selecting a laser protocol.
Documented Dose
Record the device, wavelength, power, exposure and treated area.
Activity Outcome
Repeat the same movement or task to judge whether the added treatment is useful.
Follow-Up
Use pain and function over the course to guide rehabilitation and further sessions.
§ 04
Study Parameters and Dose Selection
Wavelength
810/980 nm in one upper-trapezius trialThe 2025 upper-trapezius study used a dual-wavelength high-power device. Other HILT trials use 1064 nm. The wavelength is recorded with the device and emission settings.
Power Output
15 W device in the 2025 upper-trapezius trialThe publication also reports pulse frequency and duty cycle. Average power, peak power and treatment time should be distinguished when documenting a protocol.
Energy Density (Fluence)
No universal myofascial dose establishedEnergy density is reported in joules per square centimeter. Interpret it alongside total energy, beam area, movement and the clinical condition being treated.
Total Energy per Session
Total joules plus treated areaDocument the cumulative energy delivered and the area scanned. This allows the next session to follow a defined protocol and makes dose changes traceable.
Number of Sessions
10 sessions over two weeks in one trialThe 2025 upper-trapezius study delivered five sessions weekly alongside the same physiotherapy used by controls. Pain, neck disability and side-bending were measured before and after that course.
Session Duration
Depends on the verified device protocolTreatment time is recorded together with applied power, pulse settings and scanning area.
§ 05
Clinical Evidence
Condition-specific trialsDirect trapezius evidence; regional jaw, shoulder and back studies
Trapezius myofascial pain — PMIDs 25274197 and 41255736
A 2015 sham-controlled study in women favored HILT plus exercise for pain and neck disability at weeks 4 and 12. A 2025 trial of 40 participants also favored laser added to physiotherapy after two weeks, without an added side-bending benefit. That newer trial had no sham or later follow-up.PubMed 25274197PubMed 41255736
Myogenic TMD — PMID 34174507; online 2021, print 2022
In a 76-patient sham-controlled trial, pain favored HILT at week 4 and maximum mouth opening at week 12. The trial studied myogenic TMD as a condition, without isolating the masseter or temporalis response.PubMed 34174507
Shoulder and low-back conditions — PMIDs 33400012 and 24178907
A 63-patient subacromial-pain trial favored HILT plus exercise over sham plus exercise at weeks 3 and 12. A separate trial in 72 men with chronic low-back pain favored combined HILT and exercise. These are regional diagnosis studies, not proof of treatment for individual muscle trigger points.PubMed 33400012PubMed 24178907
Soreness after dry needling — PMID 41914595; 2026
In 64 participants, HILT after upper-trapezius dry needling did not improve immediate soreness, time to resolution or analgesic use compared with sham over seven days. This trial does not support adding HILT routinely for post-needling soreness.PubMed 41914595
Pain Reduction
Some trapezius trials favor HILT added to rehabilitation
Activity Limitation
Neck disability is a measured outcome in trapezius trials
Range of Motion
An additional movement benefit is not consistent across studies
§ 06
The Treatment Session
Confirm the Clinical Target
The clinician assesses the painful region and identifies a movement or activity to follow. Trapezius myofascial pain, myogenic jaw pain and subacromial shoulder pain have different examination and rehabilitation needs.
Inspect the Skin and Protect the Eyes
The clinician checks the treatment field and equipment. Everyone within the laser hazard area uses protection matched to the actual wavelength and exposure; the beam and reflective surfaces are controlled.
Choose a Documented Protocol
Record the device, wavelength, emission mode, power, area, energy and planned course. Select settings for the assessed condition and the actual device.
Apply the Laser
The trained operator positions and moves the handpiece according to the protocol. In the 2025 upper-trapezius study, the beam scanned longitudinally and across the symptomatic muscle region.
Respond to Discomfort
Report burning, sharply localized heat or increasing pain immediately. The operator pauses and checks the skin and settings. Pain during exposure is not a targeting test.
Recheck Movement and Continue Rehabilitation
Repeat the selected movement or activity and continue tolerable exercise. Use the response to guide loading and the need for further sessions.
§ 07
When HILT May Be Considered
Persistent Trapezius Myofascial Pain
This is the clearest direct muscle application among the reviewed studies. Consider a course when an assessed trapezius pain pattern continues to limit neck-related activity and exercise.
Myogenic Jaw Pain
An orofacial clinician may discuss HILT for persistent chewing pain or restricted opening after active and manual care. The relevant trial enrolled people with myogenic TMD.
Subacromial Shoulder Pain
HILT may accompany cuff and shoulder exercise after a clinical assessment. Pain during elevation and everyday shoulder function provide useful follow-up measures.
Chronic Low-Back Pain
A clinician may discuss regional HILT alongside exercise for continuing activity limitation. The supporting trial was small and enrolled men, so the evidence is limited.
Preference for a Treatment Without Needles
HILT does not use a needle. A preference for this approach can help choose among options that fit the assessed condition.
A Clear Activity Goal
Agree on a specific goal, such as turning the head, chewing, reaching or walking more comfortably. Reassessment determines whether the added procedure is helping the rehabilitation plan.
§ 08
Contraindications & Side Effects
Reasons to Defer Treatment
Checks Before Treatment
Side Effects
Eye and skin protection required
High-power lasers can injure the eyes and skin. A trained operator follows the device safety protocol and responds promptly to discomfort. Small efficacy trials cannot establish a precise rate of uncommon harms.
Warmth
Warmth may be felt during exposure. Report increasing heat so the operator can check the application.
Skin Redness
The operator checks a skin reaction before continuing. Persistent or painful redness needs assessment.
Pain Flare
Worsening symptoms prompt reassessment of the application and diagnosis. A flare is not evidence of a healing response.
Skin Burns
Excessive exposure can burn skin. Stop for burning discomfort; blistering or persistent skin pain requires medical review.
§ 09
HILT vs Other Treatments
Comparison
Practical DifferenceEvidence Limit
vs Low-Level Laser (LLLT)
Higher-power delivery, with different pulse and exposure settings
Trial findings and doses must be matched to the actual laser protocol
vs Shockwave (ESWT)
Laser uses light; shockwave uses acoustic pressure pulses
The appropriate choice depends on the diagnosis and comparative evidence
vs Dry Needling
No needle enters the skin
Choose according to the assessed condition and treatment preference
vs Therapeutic Ultrasound
Uses a different form of energy and a different application protocol
Active-comparator findings cannot be applied to every muscle or device
§ 10
Treatment and Reassessment
10 visits
Treatment SessionsThe 2025 upper-trapezius trial used ten visits over two weeks
Exercise
During the CourseContinue the agreed movement program and track one limited activity
Week 12
Trial ReassessmentSeveral sham-controlled studies reassessed pain and function at week 12 to examine whether improvement persisted
Key Takeaways
The clearest direct muscle evidence reviewed here concerns trapezius myofascial pain treated with HILT alongside exercise or physiotherapy.
HILT protocols vary in wavelength, power, pulse settings and scanned area. Record these variables together.
Pain during movement and tolerance of daily activity are practical measures of benefit.
Jaw, shoulder and low-back studies support regional, condition-specific discussion; direct muscle evidence is clearest for the trapezius.
One upper-trapezius trial used ten sessions over two weeks, with pain and function reassessed at the end of treatment.
HILT is a possible adjunct when the diagnosis, evidence and activity goal fit. Active rehabilitation remains part of the plan.
Eye protection and skin monitoring are essential. Burning or increasing pain calls for a pause and review, not a higher dose.